Prognostic impact of serum 25-hydroxivitamin D [25(OH)D] concentrations in patients with lymphoid malignancies

References

• Stephens JM. Chronic lymphocytic leukemia: economic burden and quality of life: literature review. Am J Ther. 2005;12:460–6.
   PubMedGoogle Scholar
• Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009;19:84–8.
   PubMed Web of Science ®Google Scholar
• Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26–34.
   PubMed Web of Science ®Google Scholar
• Lim U, Freedman DM, Hollis BW. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer. 2009;124:979–86.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98:451–9.
   PubMed Web of Science ®Google Scholar
• Lappe JM. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586–91.
   PubMed Web of Science ®Google Scholar
• Arlet JB, Callens C, Hermine O, Darnige L, Macintyre E, Pouchot J, et al. Chronic lymphocytic leukaemia responsive to vitamin D administration. Br J Haematol. 2012;156:148–9.
   PubMed Web of Science ®Google Scholar
• Toner CD, Davis CD, Milner JA. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc. 2010;110:1492–500.
   PubMed Web of Science ®Google Scholar
• Egan KM, Sosman JA, Blot WJ. Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst. 2005;97:161–3.
   PubMed Web of Science ®Google Scholar
• http://www.mayomedicallaboratories.com.
   Google Scholar
• Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1, 25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res. 2000;87:214–20.
   PubMed Web of Science ®Google Scholar
• Luong K, Nguyen LT. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol. 2009;73:192–201.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Drake MT, Maurer MJ. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 2011;117:1492–8.
   PubMed Web of Science ®Google Scholar
• Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol. 2010;28:4191–8.
   PubMed Web of Science ®Google Scholar
• Hickish T, Cunningham D, Colston K. The effect of 1, 25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer. 1993;68:668–72.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Heger A, Berlanga AJ. ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease. Genome Res. 2010;20:1352–60.
   PubMed Web of Science ®Google Scholar
• Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood. 2003;101:2454–60.
   PubMed Web of Science ®Google Scholar
• Bai M. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol. 2001;14:1105–13.
   PubMed Web of Science ®Google Scholar
• Erber E, Maskarinec G, Lim U, Kolonel LN. Dietary Vitamin D and Risk of Non-Hodgkin Lymphoma: The Multiethnic Cohort. Br J Nutr. 2010;103:581–4.
   PubMed Web of Science ®Google Scholar
• Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, et al. Interlymph Consortium. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer. 2008;122:144–54.
   PubMed Web of Science ®Google Scholar
• Armstrong BK, Kricker A. Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:396–400.
   PubMed Web of Science ®Google Scholar
• Freedman DM, Kimlin MG, Hoffbeck RW, Alexander BH, Linet MS. Multiple indicators of ambient and personal ultraviolet radiation exposure and risk of non-Hodgkin lymphoma (United States). J Photochem Photobiol B. 2010;101:321–5.
   PubMed Web of Science ®Google Scholar
• Purdue MP, Hartge P, Davis S, Cerhan JR, Colt JS, Cozen W, et al. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2007;18:989–99.
   PubMed Web of Science ®Google Scholar
• Smedby KE, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005;97:199–209.
   PubMed Web of Science ®Google Scholar
• Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, et al. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control. 2006;17:1045–52.
   PubMed Web of Science ®Google Scholar
• Soni LK, Hou L, Gapstur SM, Weisenburger DD, Chiu BC. Sun exposure and non-Hodgkin lymphoma: A population-based, case-control study. Eur J Cancer. 2007;43:2388–95.
   PubMed Web of Science ®Google Scholar
• Bertrand KA, Chang ET, Abel GA, Zhang SM, Spiegelman D, Qureshi AA, et al. Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Causes Control. 2011;22:1731–41.
   PubMed Web of Science ®Google Scholar
• Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L, et al. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. Blood. 2011;118:1591–9.
   PubMed Web of Science ®Google Scholar
• Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG. A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults. Cancer Causes Control. 2010;21:1265–75.
   PubMed Web of Science ®Google Scholar
• Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910–6.
   PubMed Web of Science ®Google Scholar
• Polesel J, Talamini R, Montella M, Parpinel M, Dal Maso L, Crispo A, et al. Linoleic acid,vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol. 2006;17:713–8.
   PubMed Web of Science ®Google Scholar
• Chang ET, Balter KM, Torrang A, Smedby KE, Melbye M, Sundstrom C, et al. Nutrient intake and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2006;164:1222–32.
   PubMed Web of Science ®Google Scholar
• Raina V, Cunningham D, Gilchrist N, Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer. 1991;63:463–5.
   PubMed Web of Science ®Google Scholar
• Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukemia. Br J Haematol. 2001;115:854–61.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Witzig TE, Fink SR. Prospective evaluation of clonal evolution during long term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol. 2006;24:4634–41.
   PubMed Web of Science ®Google Scholar